Evidence map›Paper›PMID 35323343›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021.

Eliya Farah, Maria El Bizri, Radmila Day, Lavina Matai, Fred Horne, Timothy P Hanna, David Armstrong, Susan Marlin, Olivier Jérôme, Darren R Brenner and 13 more

Abstract readConference Proceedings
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Eliya FarahColorectal Cancer Canada, Montreal, QC H3G 1J1, Canada.
Maria El BizriColorectal Cancer Canada, Montreal, QC H3G 1J1, Canada.ORCID 0000-0002-0592-4777
Radmila DayColorectal Cancer Canada, Montreal, QC H3G 1J1, Canada.
Lavina MataiColorectal Cancer Canada, Montreal, QC H3G 1J1, Canada.
Fred HorneSchool of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Timothy P HannaDepartment of Oncology, Queen's University, Kingston, ON K7L 5P9, Canada.ORCID 0000-0003-3228-6042
David ArmstrongFarncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada.
Susan MarlinClinical Trials Ontario, Toronto, ON M5G 1M1, Canada.
Olivier JérômeCATALIS-Clinical Trials Quebec, Montreal, QC H3C 3X6, Canada.
Darren R BrennerDepartment of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Winson CheungDepartment of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Laszlo RadvanyiOntario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
Eva VillalbaCoalition Priorité Cancer au Québec, Saint-Lambert, QC J4P 2J7, Canada.ORCID 0000-0001-5576-0339
Natalie LeonJewish General Hospital, Montreal, QC H3T 1E2, Canada.
Chana CohenColorectal Cancer Canada, Montreal, QC H3G 1J1, Canada.
Karine ChalifourYoung Adult Cancer Canada, St. John's, NL A1A 5C5, Canada.
Ronald BurkesMount Sinai Hospital, Toronto, ON M5G 1X5, Canada.ORCID 0000-0001-5956-3623
Sharlene GillBC Cancer, Vancouver, BC V5Z 4E6, Canada.ORCID 0000-0003-3306-3617
Scott BerryDepartment of Oncology, Queen's University, Kingston, ON K7L 5P9, Canada.ORCID 0000-0002-1453-7584
Brandon S SheffieldDivision of Advanced Diagnostics, William Osler Health Centre-Brampton Civic Hospital, Brampton, ON L6R 3J7, Canada.
Pamela FralickInnovative Medicines Canada, Ottawa, ON K1P 6L5, Canada.
Barry D SteinColorectal Cancer Canada, Montreal, QC H3G 1J1, Canada.
On Behalf Of Ready For The Next Round Patient Panelists

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The COVID-19 pandemic illuminated vulnerabilities in the Canadian health care system and exposed gaps and challenges across the cancer care continuum. Canada is experiencing significant disruptions to cancer-related services, and the impact these disruptions (delays/deferrals/cancellations) have on the health care system and patients are yet to be determined. Given the potential adverse ramifications, how can Canada's health care systems build resilience for future threats? (2) Methods: To answer this question, CCC facilitated a series of four thought-leadership roundtables, each representing the views of four different stakeholder groups: patients, physicians, health care system leaders, and researchers. (3) Results: Six themes of strength were identified to serve as a springboard for building resilience including, (1) advancing virtual care and digital health technologies to prevent future interruptions in cancer care delivery. (2) developing real-time data metrics, data sharing, and evidence-based decision-making. (3) enhancing public-private-non-profit partnerships to advance research and strengthen connections across the system. (4) advancing patient-centricity in cancer research to drive and encourage precision medicine approaches to care. (5) investing in training and hiring a robust supply of health care human resources. (6) implementing a national strategy and infrastructure to ensure inter-provincial collaborative data sharing (4). Conclusions: A resilient health care system that can respond to shocks and threats is not an emergency system; it is a robust everyday system that can respond to emergencies.

Indexed as

Colorectal NeoplasmsCOVID-19CanadaHumansLeadershipPandemicsbacklogburnoutclinical trialscolorectal cancerCOVID-19patient-centricityreal-time dataresiliencevirtual care

Identifiers

PMID35323343
PMCPMC8947543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.